InduPro was founded by K. Chris Garcia in 2022.

Who are InduPro's investors?

InduPro's investors include MRL Ventures Fund, The Column Group, Vida Ventures.

Where is InduPro headquartered?

InduPro is headquartered in Seattle, US.

InduPro

Seattle, US · Founded 2022 · 61 employees on LinkedIn · 3 known investors

Find your way into InduPro

Each arrow is one introduction. Sign up to fill in the first one.

551 people can intro you to Amanda

Ask Paris Panayiotopoulos to introduce you to Amanda J. Redig

You →Paris · together at AvenCell →Amanda

225 people can intro you to Sally

Ask Jamie Chen to introduce you to Sally Johnson

You →Jamie · together at Odyssey Therapeutics →Sally

96 people can intro you to Pamela

Ask Sam Okafor to introduce you to Pamela Holland

You →Sam · together at Alpine Immune Sciences →Pamela

Scott Lesley58 people can intro you

Your email: who you already know at InduPro, and who your contacts know
2nd- and 3rd-degree connections: people you know who worked, studied or invested with the InduPro team
Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

InduPro develops next-generation protein therapeutics by leveraging inherent and induced proximity to modulate disease biology, with a focus on ADCs and T-cell engagers. The company built proprietary platforms — Membrane Interactomics (MInt) for target discovery, ARRIS for proximity modalities using multi-specific antibody technology, and internal antibody discovery and engineering — to identify targets and design therapeutic molecules.

Biotech Deep Tech Medical Devices

Founders & leadership

InduPro was founded in 2022 by K. Chris Garcia.

K. Chris GarciaScientific Founder

Prakash RamanCEO

Amanda J. Redig Chief Medical OfficerAmanda J. Redig is a medical oncologist and physician-scientist who has worked across academic and industry settings. She serves as Chief Medical Officer at InduPro, a protein therapeutics company focused on ADCs and T-cell engagers.

Scott Lesley President & CSOScott Lesley is President and Chief Scientific Officer of InduPro, which develops protein therapeutics using proximity-modulation approaches for ADCs and T-cell engagers. He has experience in drug discovery and development spanning academic, startup, and large pharmaceutical environments, with expertise in antibody discovery, target validation, and translating research into clinical candidates.

Pamela Holland SVP of BiologyPamela Holland is SVP of Biology at InduPro, where she leads development of protein therapeutics. She brings experience in oncology, immunotherapy, and pre-clinical advancement of cancer therapeutics from basic research into clinical development.

Sally Johnson Chief People OfficerSally Johnson holds certifications in organizational coaching and human resources, with expertise in talent management and leadership development across pharmaceutical and life sciences companies. She has specialized in executive recruitment and business process management for financial services and insurance firms.

Investors · 3

MRL Ventures Fund✓ confirmed by InduProCambridge · $25M

How we know: MRL Ventures Fund's portfolio page · the company's own site · Not right? Tell us

The Column Group✓ confirmed by InduProSan Francisco · $30M

How we know: The Column Group's portfolio page · the company's own site · the VCSheet dataset · Not right? Tell us

Vida Ventures✓ confirmed by InduProLos Angeles

How we know: Vida Ventures's portfolio page · the company's own site · a partner's Signal profile · the VCSheet dataset · Not right? Tell us

Related companies · 2

Aro BiotherapeuticsAro Biotherapeutics develops tissue-targeted genetic medicines using a proprietary protein technology called Centyrins. The company builds a wholly-owned pipeline of Centyrin-based therapeutic candidates and partners with industry to enable tissue-specific targeting of therapeutics across a range of diseases.

Insitroinsitro is a drug discovery and development company that uses machine learning and cellular data to identify therapeutic insights and accelerate the creation of new medicines. The company serves patients and pharmaceutical development by integrating in vitro lab data with human clinical data to decode biology and unlock transformative treatments.

Companies working in the same space as InduPro.

Frequently asked questions

What does InduPro do?: InduPro develops next-generation protein therapeutics by leveraging inherent and induced proximity to modulate disease biology, with a focus on ADCs and T-cell engagers. The company built proprietary platforms — Membrane Interactomics (MInt) for target discovery, ARRIS for proximity modalities using multi-specific antibody technology, and internal antibody discovery and engineering — to identify targets and design therapeutic molecules.
Who founded InduPro?: InduPro was founded by K. Chris Garcia in 2022.
Who are InduPro's investors?: InduPro's investors include MRL Ventures Fund, The Column Group, Vida Ventures.
Where is InduPro headquartered?: InduPro is headquartered in Seattle, US.